Introduction
Recent studies utilizing Drosophila melanogaster genetics have indicated that merlin (Mer) and a second FERM protein called Expanded (Ex) has an important role in controlling the Salvador/Warts/Hippo (Hippo) signaling cascade (Edgar 2006; Hamaratoglu et al., 2006; Harvey and Tapon, 2007) . This pathway limits organ size by inhibiting cell proliferation and promoting apoptosis, and is therefore of particular importance during development and tissue size control (Tapon et al., 2002; Harvey et al., 2003; Huang et al., 2005; Edgar, 2006; Harvey and Tapon, 2007; Pan, 2007) . In addition, several pieces of evidence suggest that the activities of multiple Hippo pathway components are deregulated in human cancer (Tapon et al., 2002; Harvey and Tapon, 2007; Pan, 2007; Zeng and Hong, 2008) .
The Hippo pathway consists of a series of kinases and adaptor proteins in which the Hippo kinase, in association with an adaptor protein Salvador, phosphorylates and activates Warts kinase, which is associated with an activating subunit, Mats. This core kinase unit phosphorylates and inactivates the transcriptional co-activator Yorkie, thereby suppressing expression of genes that promote cell survival, growth and proliferation (Huang et al., 2005) . Inactivation of Yorkie in D. melanogaster imaginal disc tissues results in cell cycle arrest and apoptosis (Harvey and Tapon, 2007; Pan, 2007) . Ex, Mer and Kibra function upstream of the core kinase cassette, activating the pathway by an unknown mechanism via Hpo and Wts phosphorylation Genevet et al., 2010; Yu et al., 2010) . More recently, Ex has been shown to form a complex with Yorkie and is proposed to directly regulate its activity by the WW domains of YAP and the PPXY motifs of Ex (Badouel et al., 2009) . Ex is also thought to function downstream of the Hippo pathway receptor protein, Fat, an atypical cadherin that represses growth of imaginal discs (Bennett and Harvey, 2006; Silva et al., 2006; Willecke et al., 2006; Tyler and Baker, 2007) . Loss of ex results in the development of hyperplastic imaginal discs and overgrown adult structures such as the wing (Boedigheimer and Laughon, 1993) . In addition, overexpression of ex in the D. melanogaster wing and eye leads to a decrease in the number of cells in these tissues (Boedigheimer et al., 1997) .
Less is known about the functioning of the Hippo signaling pathway in mammals, particularly the proteins that regulate the mammalian Hippo pathway upstream of the core kinase cassette. Components of the Hippo pathway are conserved in mammals and consist of MST1/2 (Hpo orthologues), WW45/Sav (Sav orthologue), LATS1/2 (Wts orthologues), MOB1 (Mats orthologue) and YAP (Yki orthologue) (Harvey and Tapon, 2007) . At least four upstream regulatory branches of the Hippo pathway exist in Drosophila: Fat/Dachsous, Kibra/Ex/ Mer, Lethal Giant Larvae/atypical protein kinase C and Crumbs (Grusche et al., 2010) . The mammalian orthologues of Mer (also called NF2, Mer) and Kibra have been shown to function as upstream members of the Hippo pathway, but the identity of other upstream members of the mammalian Hippo pathway has remained enigmatic. For example, recent studies suggest that the Fat/Dachsous pathway does not control organ size and activity of the Yki orthologues, YAP and TAZ, in mice (Saburi et al., 2008; Mao et al., 2011) . Interestingly, repression of YAP by AMOT via direct interaction of the WW domains of YAP with the PPXY motifs of AMOT has been reported (Zhao et al., 2011) , a role fulfilled by the C terminus of Ex in D. melanogaster.
We sought to determine whether the mammalian homologue of D. melanogaster Ex, willin/Ex1/FRMD6, functioned as an upstream member of the mammalian Hippo pathway (Gunn-Moore et al., 2005; Hamaratoglu et al., 2006) . Previously, willin overexpression was shown to influence YAP in a luciferase activity, but a mechanistic link to the Hippo pathway was not explored (Zhao et al., 2007) . We show that increased willin expression causes phosphorylation of MST1/2, LATS1 and YAP. Loss of willin expression results in features of an epithelial-tomesenchymal transition (EMT) in MCF10A cells and willin overexpression antagonizes YAP activity by the N-terminal FERM domain of willin. The majority of willin localizes to the apical junction of D. melanogaster imaginal disc cells in a manner similar to Ex, although willin could not rescue growth defects associated with ex deficiency. Therefore, willin/Ex1/FRMD6 has both similarities and differences to Ex, but in mammalian cells willin influences Hippo signaling activity by activating the core Hippo pathway kinase cassette.
Results
Expression of willin influences phosphorylation of MST1/2, LATS1 and YAP Mammalian willin and D. melanogaster Ex show 60% similarity in their N-terminal FERM domain, but the C-terminal domains are highly divergent with Ex being much longer and containing additional functional motifs ( Figure 1a) . Previously, the expression of both willin and Mer were reported to inactivate the transcriptional coactivator YAP by an unknown mechanism (Zhao et al., 2007) . Therefore, we created a stable tetracycline-inducible HEK-293 cell line to investigate the effect of willin expression upon the kinases upstream of YAP. Cells were seeded so that the cell density remained constant, tetracycline was added to induce willin-green fluorescent protein (GFP) expression and cells were harvested at 24, 48 and 72 h. Immunoblot and subsequent image J analysis showed a significant increase in MST1/2, LATS1 and YAP phosphorylation in induced cells expressing willin-GFP when compared with uninduced HEK-293 cells (Figure 1b) . We noted that YAP phosphorylation could only be studied over a period of 2 days post-induction, as high cell density caused YAP phosphorylation in uninduced cells as was observed previously (Zhao et al., 2007) , and all experiments were therefore performed at a low cell density. No MST1/2, LATS1 and YAP phosphorylation was observed when an empty GFP plasmid was transiently transfected into the stable inducible cell line or when 1 mg/ ml tetracycline was added to cells that did not contain the pcDNA4/TO/myc-his willin-GFP plasmid, but only a plasmid expressing the pcDNA6-TR tetracycline repressor (data not shown).
Ezrin modulates the ability of willin to phosphorylate MST1/2 To investigate the effect of the expression of other FERM domain-containing proteins on MST1/2 phosphorylation, we expressed combinations of Mer and ezrin in TRex-willin-GFP cells and induced willin-GFP expression with 1 mg/ml tetracycline. A hierarchy in the ability to activate MST1/2 phosphorylation was observed, in which the expression of either Mer or willin was sufficient to result in MST1/2 phosphorylation ( Figure 1c ). When Mer and willin were co-expressed, a synergistic effect was observed on MST1/2 phosphorylation, in which willin expression enhances Mer's ability to phosphorylate MST1/2 (Po0.01). Interestingly, ezrin expression was found to have an inhibitory effect on MST1/2 phosphorylation when co-expressed with Mer, willin or willin and Mer (Po0.01) (Figure 1c ).
Willin expression sensitizes HEK-293 cells to apoptotic stimuli Previous studies have shown that MST1/2 expression sensitizes cells to death upon addition of tumor necrosis factor-a (TNFa) and cycloheximide (Lee et al., 2001) . Therefore, we explored whether willin-GFP expression in HEK-293 cells could also sensitize these cells to cell death signals. Interestingly, MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assays showed that cell viability dropped by 20% in cells treated with TNFa that expressed willin-GFP as compared with uninduced cells (Figure 2a) . Furthermore, immunoblot analysis showed that caspase-3 was cleaved in these cells only upon willin-GFP expression (Figure 2b) . A colorimetric assay supported these observations as active caspase-3 was detected in cells expressing willin-GFP treated with TNFa, whereas no caspase-3 activity was observed in the control (TRex) cells (Figure 2b) .
Other studies have shown that both phosphorylation and cleavage of MST1 are required for apoptotic downstream effects (Graves et al., 2001) . Therefore, MST1 cleavage was investigated in the absence and presence of TNFa. MST1 cleavage was never observed when cells were induced for willin-GFP expression. However, addition of TNFa did result in MST1 cleavage, which was enhanced upon willin-GFP expression (Figure 2c ).
Previous studies have observed nuclear-to-cytoplasmic translocation of YAP upon phosphorylation at Ser127 through binding to 14-3-3 proteins (Zhao et al., 2007) . Therefore, we investigated the subcellular localization of YAP following willin-GFP expression. A cytoplasmic/nuclear fractionation assay showed that YAP is mainly located in the cytoplasmic fraction of willin-GFP-expressing cells and TNFa treatment does not further influence this localization, whereas YAP remained mostly within the nucleus in uninduced cells (Figure 2d ).
Willin shares similar subcellular localization as Ex, but cannot rescue the growth defect of Ex clone in D. melanogaster To assess whether willin could function in a manner similar to its closest D. melanogaster sequence homologue (Ex) in D. melanogaster tissues, we assessed willin subcellular localization, the effect of willin misexpression and whether willin could substitute for Ex. To perform these experiments, we generated a transgenic D. melanogaster strain that afforded inducible expression of the willin protein with GFP fused to its carboxyl terminus. Ex is localized predominantly to the apical junction of D. melanogaster epithelial imaginal disc cells, along with other Hippo pathway proteins such as Fat (Bennett and Harvey, 2006; Silva et al., 2006; Willecke et al., 2006) . Ex also localizes to punctuate cytoplasmic structures thought to be vesicles. Using the wing-specific 32B-Gal4 driver, we expressed willin-GFP in developing wing imaginal discs and also stained these tissues with Ex-and Fat-specific antibodies. The majority of willin-GFP was localized at the subapical When overexpressed in developing imaginal discs ex causes a substantial reduction in organ size ( Figure 3h ). To determine whether willin could limit size of imaginal disc-derived tissues, we misexpressed willin-GFP with 32B-Gal4. Unlike overexpression of ex, misexpression of willin-GFP did not reduce the total area of adult wings as compared with wings expressing GFP under control of the 32B promoter, or flies harboring 32B-Gal4 or UAS-willin-GFP alone (Figures 3g-j) . Similar results were observed for other wing Gal4 drivers such as C5, MS1096 and 71B (data not shown). We did observe a slight change in the shape of wings misexpressing willin-GFP; however, wings were slightly broadened across the anterior/posterior axis relative to the proximal-distal axis, although the biological relevance of this result is unclear (Figures 3j and k) . Several mammalian Hippo pathway proteins can compensate for loss of their D. melanogaster counterparts with respect to the ability to modulate organ size. To determine whether willin could compensate for ex loss, we overexpressed willin-GFP in clones of third instar larval eye imaginal disc tissue lacking ex gene function, using the mosaic analysis with a repressible cell marker technique (Lee and Luo, 1999) . Compared with wild-type control clones, ex MGH1 clones were larger and rounded in shape, and occupied more tissue relative to GFP-negative control tissue (Figures 3l and m) . ex MGH1 clones displayed high Yki activity as determined by assessing expression of the Hippo pathway target proteins, Ex ( Figure 3m ) and DIAP1 (data not shown). When willin-GFP was misexpressed in ex MGH1 clones, no substantial changes in size or shape of the clones were observed, and the Hippo pathway target proteins, Ex and DIAP1, were still expressed at high levels ( Figure 3n and data not shown). These data show that the closest human sequence homolog of ex, willin, cannot functionally substitute for the ability of ex to control Hippo pathway-dependent tissue growth in D. melanogaster.
Willin/FRMD6 knockdown induces features of EMT in mammary epithelial cells As deregulation of Hippo pathway components such as YAP induces EMT in MCF10A cells (Overholtzer et al., 2006; Zhang et al., 2008) , we knocked down the expression of willin in these cells using two independent lentiviral short hairpin RNA (shRNA) constructs. Although MCF10A cells expressing a non-targeting Figure 4e ). MCF10A-shWillin cells produced threefold more colonies in soft agar than MCF10A-shScr cells, after 21 days in culture (Figure 4c ). MCF10A-shWillin cells also showed a threefold increased migration compared with MCF10A-shScr cells (Figure 4d) . Consistent with the EMT-like phenotype, expression of the mesenchymal markers N-cadherin and vimentin was upregulated by YAP overexpression or by willin knockdown, whereas the epithelial markers, E-cadherin and occludin, were downregulated by both of these manipulations (Figure 4e ). Knockdown of Mer (shMerlin) also displayed a similar phenotype. When small interfering RNAs (siRNAs) targeting YAP were introduced into MCF10A-shWillin cells, they abrogated the willin knockdown migration phenotype ( Figure 4f ).
Willin expression antagonizes a YAP-induced EMT phenotype in MCF10A cells Next, we investigated whether expression of willin could influence the activity of YAP in MCF10A cells. These cells were infected with a retrovirus-expressing willin or empty vector and an increase in MST1/2, LATS1 and YAP phosphorylation were all observed when MCF10A cells overexpressed willin (Figure 5a ). Then, we explored whether willin expression could antagonize a YAPinduced EMT phenotype in MCF10A cells overexpressing YAP (MCF10A-YAP) that were infected with a retrovirus containing an empty vector or willin cDNA. Notably, MCF10A-YAP cells expressing willin produced approximately 50% fewer colonies in soft agar than MCF10A-YAP cells containing empty vector, after 21 days in culture (Figure 5b ). Moreover, willin was unable to antagonize a YAP(S127A) mutant under the same conditions (Figure 5b ). MCF10A-YAP cells expressing willin also showed attenuated migration by 50% compared with MCF10A-YAP cells containing empty vector, whereas MCF10A-YAP(S127A) cells were refractory to the effects of willin expression (Figure 5c ). Mesenchymal and epithelial markers also changed: with a decrease of the mesenchymal markers vimentin and N-cadherin in MCF10A-YAP cells expressing willin and an increase in the epithelial markers occludin and E-cadherin in these cells, but no changes were observed in MCF10A-YAP(S127A) cells (Figure 5d ). (Figure 6d ).
Discussion
Although the core kinase cassette of the Hippo pathway has been well characterized in mammalian cells, events upstream are far less understood. We have shown for the first time that willin expression can activate components of the Hippo signaling pathway in mammalian cells. We find that an increase in willin expression causes phosphorylation of MST1/2, LATS1 and YAP. Ezrin, which is absent in D. melanogaster but present in mammals, inhibits the effect of both Mer and willin on MST1/2 phosphorylation in HEK-293 cells. Therefore, it is possible that ezrin is an important controlling mechanism for upstream activation of the Hippo pathway in mammals. Furthermore, nuclear-to-cytoplasmic YAP translocation was observed in both HEK-293 and MCF10A cells expressing willin, which may explain the observation that willin expression results in sensitizing cells to TNFa-induced cell death. Although phosphorylation of MST1/2 (and also LATS1 and YAP) occurred upon willin expression, cleaved MST1 was never observed in this scenario. Only upon TNFa stimulation was MST1 cleaved and an apoptotic downstream effect observed. Interestingly, and n 00 ) and ELAV (red in the merged images, l 00 , m 00 and n 00 ) was determined. ex MGH1 clones were larger than control clones and displayed elevated Ex protein, regardless of whether willin-GFP was misexpressed. Many Hippo pathway proteins can rescue the function of their orthologues in D. melanogaster tissues, emphasizing the high degree of conservation inherent in this pathway. When misexpressed in D. melanogaster larval imaginal discs, willin displayed an overlapping localization, that is, predominantly localized at the apical junction of epithelial cells. Despite this, willin did not display growth-suppressive activity in D. melanogaster tissues. In addition, willin mis-expression did not limit the size of D. melanogaster wings and it failed to rescue the overgrowth defect and elevated Yki activity associated with ex deficiency. The ex gene is significantly larger than the willin gene, and may have split its functions during vertebrate evolution. The Ex and willin proteins are especially divergent in the carboxyl termini, which is the region of Ex that is proposed to bind to and inhibit Yki (Badouel et al., 2009 ). In D. melanogaster, Yki is believed to contact Ex via WW domain-PY motif interactions, but none of the three PPXY motifs in the Ex C terminus are conserved in willin. Thus, it appears that the direct mode of inhibition of Yki function by Ex is not conserved between willin and YAP in mammals. Interestingly, repression of YAP by AMOT via direct interaction of the WW domains of YAP with the PPXY motifs of AMOT has been reported (Zhao et al., 2011) , and AMOT may fulfill the role of the C terminus. Ex has also been proposed to function upstream of the core components of the Hippo pathway and influence activity of the Warts kinase Genevet et al., 2010; Yu et al., 2010) . Our data support this proposed mode of regulation.
We found that ectopic willin expression antagonized a YAP-induced EMT phenotype in MCF10A cells, both in terms of changes in functional outputs of anchorageindependent growth and migration, but also changes in marker expression. Furthermore, willin could not antagonize a constitutively active YAP mutant (YAP-S127A), showing that the action of willin on YAP is by Ser127 phosphorylation. These cells are a non-tumorigenic, human mammary epithelial cell line in which, importantly, other Hippo pathway components have been shown to induce EMT (Overholtzer et al., 2006; Zhang et al., 2008) . Moreover, the conserved FERM domain of willin is sufficient to antagonize a YAPinduced EMT phenotype in MCF10A cells and is able to control the downstream targets of YAP activity. We propose a model (Figure 6e ) whereby upstream signals acting on willin and Mer are antagonized by ezrin. As the FERM domain is a known protein-binding motif, we speculate that the FERM domain of willin acts as a scaffold and binds other proteins that elicit the observed effects on the core Hippo pathway. Importantly, not all FERM domain-containing proteins can activate the Hippo Pathway, as we have shown that ezrin has an inhibitory effect. Indeed, the FERM domain of willin may act to block the inhibitory effects of ezrin.
The reduction of endogenous willin expression was also able to induce an EMT in MCF10A cells with a similar phenotypic trend to YAP overexpression both in terms of morphological changes, but also cell marker expression. Specifically, epithelial markers E-cadherin and occludin were downregulated and the mesenchymal markers N-cadherin and vimentin were upregulated. These effects of willin knockdown were YAP dependent. The ability of willin knockdown to induce an EMT was further confirmed through an increase in cell migration and anchorage-independent growth in soft agar. This all suggests that willin is involved, together with other members of the mammalian Hippo pathway, in the negative regulation of YAP. However, although other members of the pathway (Mer, LATS, MOB1, YAP) have been linked to tumorigenesis (Harvey and Tapon, 2007) , the question of whether willin is a tumor suppressor gene in human cancer awaits further analysis, as no studies have addressed if this gene is mutated or silenced in cancer. Interestingly, other FERM domain-containing proteins have been implicated in cancer, for example, FRMD3 is silenced in non-small-cell lung carcinoma (Haase et al., 2007) . . Immunoblot analysis of efficient knockdown of YAP was carried out using two independent siRNA duplexes (siYAP1 and siYAP2). siControl refers to a non-targeting siRNA duplex. b-Actin was used as a loading control.
To conclude, we have shown that willin expression can activate the Hippo signaling pathway resulting in the sensitization of mammalian cells to apoptotic stimuli, and willin acts antagonistically to YAP. As with D. melanogaster Ex, the precise mechanism by which willin regulates phosphorylation and activation of the Hippo pathway core kinase cassette is unknown. Our findings place willin in the Hippo signaling pathway in mammals, and raise the possibility that YAP activity is modulated by the combined effects of willin, Mer and other effectors acting upstream of the core components of the Hippo pathway core kinase cassette.
Materials and methods
Cell culture and transfection HEK-293 cells were grown in minimum essential medium supplemented with 10 mM non-essential amino acids, 10% fotal bovine serum, 2 mM glutamine, 100 mg/ml streptomycin, 100 U of penicillin per ml at 37 1C and atmosphere of 5% CO 2 . MCF10A cells were obtained from American Type Culture Cells and were grown according to Debnath et al. (2003) in standard cell culture flasks (Nunc Nunclon) in a humidified incubator at 37 1C with 5% CO 2 . A stable tetracycline-inducible system was created using a TRex-inducible plasmid pcDNA4/TO/myc-his (Invitrogen, Paisley, UK), cloned to contain willin-GFP, which was then transfected into stable HEK cells containing a plasmid expressing tetracycline repressors, pcDNA6/TR, a kind gift from Dr C Tate (MRC, Laboratory of Molecular Biology, Cambridge, UK). Stable cells were selected by the addition with 5 mg/ml blasticidin and 250 mg/ml zeocin. Willin-GFP expression was induced with 1 mg/ml tetracycline (Invitrogen).
Expression vectors were obtained as follows: pGFP-ezrin was a generous gift from Dr R Lamb, Cancer Research UK Centre of Cell and Molecular Biology, Institute of Cancer Research, London, UK; pmerlin-GFP and pcDNA3-merlin-FLAG from Dr W IP, University of Cincinnati, Cincinnati, OH, USA; willin-HA (pBabe-puro; Addgene, Cambridge, MA, USA); pBabe-Flag-YAP (Addgene plasmid 15682) has been previously described (Overholtzer et al., 2006; Zhang et al., 2008) ; pBabe-Flag-YAP(S127A) was a kind gift from Dr D Haber (Harvard University, Harvard, MA, USA). Willin- Salvador/Warts/Hippo signaling pathway in mammals L Angus et al GFP, TRex-willin-GFP (pcDNA4/TO/myc-his; Invitrogen), Flag-YAP, willin-FERM-HA and willin-Cterm-HA plasmids were cloned in our lab.
For microscopy studies, HEK-293 cells were plated onto glass coverslips and transfected with 1 mg of DNA per coverslip using GeneJammer (Agilent, Stockport, UK). Cells were left for 24-48 h, after which they were washed twice with phosphate-buffered saline, fixed in neutral-buffered formalin (10% formalin, 0.4% NaH 2 PO 4 Á H 2 O, 0.65% Na 2 HPO 4 ), washed again with phosphate-buffered saline and then mounted with mowiol (Merck Chemicals, Nottingham, UK) and 4 0 ,6-diamidino-2-phenylindole (Sigma-Aldrich, Gilingham, UK). For biochemical studies, HEK-293 cells were plated onto 90 or 150 mm dishes and transfected with 6 or 20 mg of DNA per dish, respectively, using GeneJammer (Agilent).
pBabe constructs were packaged in Phoenix A cells for viral propagation. Retroviral infection of MCF10A cells was carried out using standard methods. Puromycin selection (2 mg/ml) or hygromycin selection (300 mg/ml) was applied 24 h after retroviral infection and continued for 5 days (puromycin) or 8 days (hygromycin), after which cells were harvested or used for further experiments. The shRNA duplex hairpins against human willin (19mer target sequences: Willin-A, 5 0 -ACAGAGCAGCAAGATACTA-3 0 , Willin-B, 5 0 -TTCATT CTCAGTGTGTGCT-3 0 ) and Mer (Okada et al., 2005) were synthesized and cloned into pLKO.1puro (Addgene; plasmid 8453). Control shScr was obtained from Addgene (plasmid 1864). Constructs were packaged in HEK-293T for viral propagation. Lentiviral infection of MCF10A cells was carried out using standard methods and drug selection was performed following standard protocols. siRNAs targeting YAP (siYAP1 and siYAP2) along with their siRNA control were purchased from Ambion, Warrington, UK.
Immunoblot analysis
Cells were lysed in 10 mM Tris (pH 8.0), 150 mM NaCl, 1% Na deoxycholate, 1% Nonidet P-40, 1% sodium dodecyl sulfate, 1 mM ethylenediaminetetracetic acid and protease inhibitor. Proteins were separated on a sodium dodecyl sulfate gel and proteins were equally loaded. After transfer onto either polyvinylidene fluoride or nitrocellulose membrane (GE Healthcare, Amersham, UK), protein expression was detected by specific antibodies. Primary antibodies used were: MST1/2, Phospho-MST1(Thr183)/MST2 (Thr180), LATS1, Phospho-LATS1(Ser909), YAP, Phospho-YAP(Ser127) (Cell Signaling Technology, Hitchin, UK), E-cadherin, N-cadherin, vimentin (BD Biosciences, Oxford, UK), Mer (Abcam, Cambridge, UK), and caspase-3, coilin, occludin, FLAG and b-actin (Sigma-Aldrich). Secondary antibodies used were anti-mouse horseradish peroxidase and anti-rabbit horseradish peroxidase (Santa Cruz, CA, USA). Protein expressions on immunoblots were analyzed using image J analysis and a Student's unpaired t-test was performed to test significance.
TNFa treatment and MTT assay
Cells were plated in 96-well plates in a total of 100 ml medium. Both TRex and TRex-willin-GFP cells were incubated in 1 mg/ml tetracycline 2 days before a 4 h 50 ng/ml TNFa treatment. After this treatment, MTT solution was added to a final concentration of 1 mg/ml and left to incubate for 3 h in a sterile tissue culture incubator at 37 1C. All medium was removed and 100 ml dimethylsulfoxide was added into each well. Plates were shaken for 1 min and absorbance was read at 570 nm using MRX Microplate Reader (DYNEX Technologies, Worthing, UK).
Colorimetric caspase-3 assay
All materials for the caspase-3 assay came from the caspACE colorimetric assay kit (Promega, Southampton, UK) and protocol used was according to the manufacturer's handbook. A total of 25 ng of protein extract was used for the caspase-3 assay and absorbance was measured at 405 nm using a MRX Microplate Reader (DYNEX Technologies).
Nuclear/cytoplasmic fractionation Cells were grown in two 90 mm dishes, and when desired density was reached, cells were pelleted at 300 g for 5 min at 4 1C. Pellet was resuspended in 0.5 ml ice-cold cytoplasmic extraction buffer (10 mM HEPES, pH 7.9, 1.5 mM MgCl 2 , 10 mM KCl, 0.5 mM dithiothreitol) and incubated on ice for 5 min. Cells were lysed with 20 stokes on Dounce homogenizer and lysate was centrifuged at 228 g for 5 min at 4 1C to pellet nuclei and other fragments. The supernatant, containing the cytoplasmic fraction, was stored at À20 1C. Nuclear pellet was resuspended in 0.5 ml ice-cold nuclear extraction buffer (0.25 mM sucrose, 10 mM MgCl 2 ) and layered over a sucrose bed (0.88 mM sucrose, 0.5 mM MgCl 2 ). Nuclear fraction was pelleted by centrifugation at 2800 g for 10 min at 4 1C. Protein sample buffer was added to both nuclear and cytoplasmic fractions and run on a sodium dodecyl sulfate gel.
Soft agar assay
Cells were seeded at 2 Â 10 4 cells per well in 0.35% agarose/ Dulbecco's modified Eagle's medium:F12 complete media onto a lower layer of 0.5% agarose/Dulbecco's modified Eagle's medium:F12 complete media. Once the agarose was set, a layer of Dulbecco's modified Eagle's medium:F12 complete media were added above the agarose layers. This media were replaced every other day and the number of colonies (X5 cells represented a colony) in each well were counted after 21 days.
Migration assay
A measure of 0.5 ml aliquots of serum-free cell suspension (5 Â 10 5 cells) were added to the top chamber of 24-well chambers with 8.0 mm pores (BD Biosciences) and media supplemented with 20% serum were added to the lower chamber. After 24 h, the top of the insert membrane was scrubbed free of cells by using a cotton swab and phosphatebuffered saline washes, and the bottom side was stained with 0.1% crystal violet (Sigma-Aldrich). The number of cells on the lower surface of each chamber was either counted or dye was extracted with 500 ml 0.1 M sodium citrate in 50% ethanol and absorbance was measured at 570 nm.
RNA isolation and quantitative real time PCR
Isolation of RNA from cell pellets was carried out using an RNeasy Mini Kit (Qiagen, Crawley, UK). Transcriptor Reverse Transcriptase (Roche, Burgess Hill, UK) was used to synthesize cDNA from 2 ml of the DNase-digested RNA. Quantitative PCR was performed using a SYBR green assay and an Mx3005P machine (Stratagene) and primers corresponding to willin or b-actin (amplifying 494-2338 of NM_001042481 and 496-885 of NM_001101) or PRL (NM000948), IGFBP3 (NM001013398), BMP2 (NM001200) or RASSF8 (NM001164746).
D. melanogaster stocks
Misexpression experiments used the following stocks: 32B-Gal4, 71B-Gal4, MS1096-Gal4, C5-Gal4, UAS-ex and UASwillin-GFP. The mosaic analysis with a repressible cell marker technique was used to express willin-GFP in ex MGH1 mutant cells. Genotypes of mosaic analysis with a repressible cell marker experiments were as follows: y w hs-FLP UAS-GFP; Tub-GAL80 FRT40/ex MGH1 FRT40; Tub-GAL4/ UASwillin-GFPy w hs-FLP UAS-GFP; Tub-GAL80 FRT40/ ex MGH1 FRT40; Tub-GAL4/ þ and y whs-FLPUAS-GFP; and Tub-GAL80 FRT40/FRT40;Tub-GAL4/ þ . All fly stocks were grown at 24 ± 1 1C.
D. melanogaster tissue immunohistochemistry
Antibodies used were as follows: anti-Fat (Milton et al., 2010) , anti-Ex (from Allen Laughon, University of Wisconsin, Madison, WI, USA), anti-ELAV (DSHB), and anti-rabbit and anti-rat secondary antibodies (Invitrogen). Tissues were fixed in 4% paraformaldehyde, washed with phosphatebuffered saline containing 0.3% Triton X-100, incubated with antibodies overnight at 4 1C in phosphate-buffered saline and 0.1% Triton X-100 and mounted in 90% glycerol as in Zhang et al. (2009) . Images were collected on an Olympus Confocal microscope and processed using Olympus Confocal Fluoview FV1000 software and Adobe Photoshop.
D. melanogaster wing measurements
Adult wings were mounted in Canada Balsam with xylene and imaged using an Olympus BX-51 microscope. Wing area was measured using Adobe Photoshop by taking the number of pixels bound within the wing circumference. Wing shape was measured by taking the ratio of lengths along the anteriorposterior and proximal-distal axes. t-tests were used to determine whether changes in size or shape were statistically significant.
